Longevity

October 10, 2017

Lifespan extension therapy:  Berberine, isolated from Berberis,  increases life span via up-regulation of its target gene BubR1, 11/October/2016, 12.01 am

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]
October 9, 2017

Lifespan extension therapy: Glyburide, an anti- hyperglycemic medication,   increases life span via up-regulation of its target gene BubR1, 9/October/2016, 11.18 pm

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]
October 8, 2017

Lifespan extension therapy: Glimpride, an anti- hyperglycemic medication, increases life span via up-regulation of its target gene BubR1, 8/October/2016, 11.59 pm

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]
October 8, 2017

Natural product-based therapy for ageing-associated diseases: A therapeutic mix encompassing Fucoxanthin, Ursolic acid and Naringenin (FUN), isolated from Brown algae, Olive oil, Miralis Jalba, and Grape fruits, respectively, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 8/October/2017, 12.57 pm

  Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; […]